Orphan Drugs Market Business Overview and Global Development Trends – Forecast to 2022 | AbbVie, Aegerion Pharmaceuticals, Bristol-Myers Squibb Company, Celgene

Press Release

The report on “Orphan Drugs Market” will help Major Players and the new entrants to understand scrutinize the market in detail. This information will encourage the Major Players to decide their business strategy and achieve proposed business aims.

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billion by 2022, registering a CAGR of 6.8% from 2016 to 2022.

Orphan drugs are used to treat rare (orphaned) diseases prevalent in a very small patient pool. Hence, the pharmaceutical industry takes little interest in their development. Moreover, their development requires high cost and the chances of returns on investment are comparatively less when compared to non-orphan drugs. These drugs treat different rare diseases, such as non-Hodgkin lymphoma, acute myeloid leukemia, cystic fibrosis, and others.

Top Companies Covered in this Report:
AbbVie Inc., Aegerion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd. , GlaxoSmithKline plc, Johnson & Johnson., Novartis AG, Pfizer Inc., Sanofi

Get sample copy of “Orphan Drugs” at: https://www.premiummarketinsights.com/sample/AMR00013189

Conducive government regulations and market exclusivity for orphan drugs drives the global orphan drugs market. In addition, surge in prevalence of rare diseases and rise in investment in research, drug development, and innovation supplement the market growth. However, limited patient pool for clinical trials & product marketing and high treatment costs per patient impede the market growth. Furthermore, growth in novel indications for known orphan drugs and untapped emerging markets offer lucrative opportunities for the market players.

The orphan drugs market is segmented based on disease type, indication, and geography. Based on disease type, the market is divided into oncologic diseases, metabolic diseases, hematologic and immunologic diseases, infectious diseases, neurologic diseases, and other rare diseases. In the orphan drugs disease type segment, oncologic diseases occupied dominant share in 2015, and the segment is expected to maintain this trend during the forecast period. This is attributed to the array of different forms of rare cancers, such as leukemia, myeloma, angiosarcoma, and others prevalent in the patient population.

Based on indication, this market is classified into non-Hodgkin lymphoma, acute myeloid leukemia, cystic fibrosis, glioma, pancreatic cancer, ovarian cancer, multiple myeloma, Duchenne muscular dystrophy, Graft vs host disease, renal cell carcinoma, and others. The non-Hodgkin lymphoma was the highest revenue contributor in 2015, while renal cell carcinoma is anticipated to grow at the highest rate. The growth for this segment is due to increase in investment in R&D throughout the world along with surge in awareness about kidney cancer.

Have any query? Enquire about report at: https://www.premiummarketinsights.com/discount/AMR00013189

Fundamentals of Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Orphan Drugs Market Size
2.2 Orphan Drugs Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 Orphan Drugs Market Size by Manufacturers
3.2 Orphan Drugs Key Players Head office and Area Served
3.3 Key Players Orphan Drugs Product/Solution/Service
3.4 Date of Enter into Orphan Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Orphan Drugs Sales by Product
4.2 Global Orphan Drugs Revenue by Product
4.3 Orphan Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Orphan Drugs Breakdown Data by End User

Get Complete Report at: https://www.premiummarketinsights.com/buy/AMR00013189

Contact Us:                                          
Call: +912067274191
Email: [email protected]

About Premiummarketinsights:

Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.